BG61340B1 - Benzene-dimethanol derivative, suitable micronizating - Google Patents

Benzene-dimethanol derivative, suitable micronizating Download PDF

Info

Publication number
BG61340B1
BG61340B1 BG97767A BG9776793A BG61340B1 BG 61340 B1 BG61340 B1 BG 61340B1 BG 97767 A BG97767 A BG 97767A BG 9776793 A BG9776793 A BG 9776793A BG 61340 B1 BG61340 B1 BG 61340B1
Authority
BG
Bulgaria
Prior art keywords
salt
organic
microcrystals
spherically
hot
Prior art date
Application number
BG97767A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG97767A (bg
Inventor
Stephen F Beach
David W Latham
Tony G Roberts
Colin B Sidgwick
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BG97767A publication Critical patent/BG97767A/bg
Publication of BG61340B1 publication Critical patent/BG61340B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Saccharide Compounds (AREA)
BG97767A 1990-11-29 1993-05-25 Benzene-dimethanol derivative, suitable micronizating BG61340B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909026005A GB9026005D0 (en) 1990-11-29 1990-11-29 Drug material suitable for micronisation
PCT/GB1991/002108 WO1992009557A1 (en) 1990-11-29 1991-11-28 Benzenedimethanol suitable for micronisation

Publications (2)

Publication Number Publication Date
BG97767A BG97767A (bg) 1994-12-02
BG61340B1 true BG61340B1 (en) 1997-06-30

Family

ID=10686212

Family Applications (1)

Application Number Title Priority Date Filing Date
BG97767A BG61340B1 (en) 1990-11-29 1993-05-25 Benzene-dimethanol derivative, suitable micronizating

Country Status (27)

Country Link
US (1) US5380922A (xx)
EP (2) EP0639176B1 (xx)
JP (1) JP3375626B2 (xx)
KR (1) KR100192196B1 (xx)
AT (1) ATE144244T1 (xx)
AU (1) AU644505B2 (xx)
BG (1) BG61340B1 (xx)
CA (1) CA2099586C (xx)
CY (1) CY2009A (xx)
CZ (1) CZ282996B6 (xx)
DE (1) DE69122780T2 (xx)
DK (1) DK0639176T3 (xx)
ES (1) ES2093812T3 (xx)
FI (2) FI118155B (xx)
GB (1) GB9026005D0 (xx)
GR (1) GR3022088T3 (xx)
HK (1) HK78997A (xx)
HU (1) HU218205B (xx)
IE (1) IE914146A1 (xx)
OA (2) OA09861A (xx)
PL (2) PL169722B1 (xx)
RU (2) RU2197475C2 (xx)
SG (1) SG49741A1 (xx)
SK (1) SK281095B6 (xx)
TW (1) TW309425B (xx)
WO (1) WO1992009557A1 (xx)
ZA (1) ZA919401B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
WO1993016031A1 (en) * 1992-02-11 1993-08-19 Glaxo Group Limited Benzenedimethanol derivative suitable for micronisation
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
US7090831B1 (en) 1999-04-14 2006-08-15 Smithkline Beecham Corporation Pharmaceutical aerosol formulation
EP1328278A4 (en) 2000-09-26 2004-06-16 Univ Temple ANALGETIC AND GLUCOSAMINE COMPOSITIONS
EP2127641A1 (en) * 2008-05-26 2009-12-02 Inke, S.A. Micronisable form of salmeterol xinafoate
KR101100614B1 (ko) 2010-09-20 2011-12-29 한국수력원자력 주식회사 농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법
WO2016142582A1 (en) 2015-03-11 2016-09-15 Fermion Oy Process for the preparation of crystalline salmeterol and its xinafoate salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation

Also Published As

Publication number Publication date
CA2099586C (en) 2002-06-25
IE914146A1 (en) 1992-06-03
FI932422A (fi) 1993-05-27
FI932422A0 (fi) 1993-05-27
ATE144244T1 (de) 1996-11-15
EP0639176B1 (en) 1996-10-16
TW309425B (xx) 1997-07-01
CZ101993A3 (en) 1994-01-19
RU2116293C1 (ru) 1998-07-27
EP0571669B1 (en) 1996-03-06
ES2093812T3 (es) 1997-01-01
FI118203B (fi) 2007-08-31
RU2197475C2 (ru) 2003-01-27
CZ282996B6 (cs) 1997-12-17
HK78997A (en) 1997-06-20
HUT64219A (en) 1993-12-28
HU218205B (hu) 2000-06-28
DE69122780T2 (de) 1997-02-20
PL167976B1 (pl) 1995-12-30
BG97767A (bg) 1994-12-02
FI982081A0 (fi) 1998-09-28
FI982081A (fi) 1998-09-28
CY2009A (en) 1998-02-20
US5380922A (en) 1995-01-10
AU644505B2 (en) 1993-12-09
OA09861A (en) 1994-08-15
EP0639176A1 (en) 1995-02-22
EP0571669A1 (en) 1993-12-01
DE69122780D1 (de) 1996-11-21
WO1992009557A1 (en) 1992-06-11
OA10024A (en) 1996-10-14
AU9040291A (en) 1992-06-25
FI118155B (fi) 2007-07-31
KR100192196B1 (en) 1999-06-15
SG49741A1 (en) 1998-06-15
JPH06503082A (ja) 1994-04-07
GR3022088T3 (en) 1997-03-31
ZA919401B (en) 1992-07-29
PL169722B1 (pl) 1996-08-30
SK281095B6 (sk) 2000-11-07
HU9301568D0 (en) 1993-09-28
DK0639176T3 (da) 1996-12-23
JP3375626B2 (ja) 2003-02-10
GB9026005D0 (en) 1991-01-16
SK54593A3 (en) 1993-10-06
CA2099586A1 (en) 1992-05-30

Similar Documents

Publication Publication Date Title
JP5317960B2 (ja) 微粉砕化有機化合物粒子の製造方法
BG61340B1 (en) Benzene-dimethanol derivative, suitable micronizating
JP2024028953A (ja) 新規非晶質活性医薬成分
Westmeier et al. Combination particles containing salmeterol xinafoate and fluticasone propionate: Formulation and aerodynamic assessment
EA039449B1 (ru) Слаборастворимый комплекс или его сольват, фармацевтическая композиция и их применение
CN112972384B (zh) 一种格隆溴铵和茚达特罗原料药微粉混合物的制备方法
AP323A (en) Drug material suitable for micronisation.
EP2303232B1 (en) Micronisable form of salmeterol xinafoate
WO1993016031A1 (en) Benzenedimethanol derivative suitable for micronisation
SI9200252A (sl) Zdravilni material, primeren za mikronizacijo
US20020072602A1 (en) Micronized mirtazapine
CN1056974C (zh) 适宜于微粒化的药物材料的制备方法
IL101798A (en) 1-hydroxy-2-naphthalene carboxylate (hydroxynaphthoate) salt of 4-hydroxy- alpha1-[[[6-4-phenylbutoxy) hexyl] amino] methyl]-1,3-benzenedimethanol suitable for micronisation
TW202342434A (zh) 卡利拉嗪藥用鹽及其晶型、藥物組合物、製備方法和用途
NZ240788A (en) 1-hydroxy-2-naphthalene carboxylate salt of 4-hydroxy- alpha 1
WO2007064311A1 (en) Micronized mirtazapine
JPH03178990A (ja) クロロフルオロカーボンを基剤とした微細結晶計量エアゾールでの使用に適する特別の結晶性向を示すジプロピオン酸ベクロメタゾンの製造方法